Vera Therapeutics Inc. has announced new compensation terms under its Inducement Plan, following the grant of inducement awards by the company's Compensation Committee on July 6, 2025. These awards include non-qualified stock options for 133,500 shares of Class A common stock, with an exercise price of $24.00 per share, and restricted stock units (RSUs) for 73,695 shares. The stock options will vest over four years, with 25% vesting one year after the vesting commencement date, and the remainder vesting monthly over the next 36 months. The RSUs will also vest over four years, with 25% vesting annually starting from August 20, 2025. These grants, made in accordance with Nasdaq Listing Rule 5635(c)(4), are part of the company's efforts to attract new talent.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。